Company patents
NEUBORON THERAPY SYSTEM LTD.
NEUBORON THERAPY SYSTEM LTD. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in Electrotherapy / Radiation Therapy, a surprising focus given the broader medical device landscape. While this core area saw a significant surge in 2025 with 22 patents (a +46.7% YoY increase), the sharp decline to 5 patents so far in 2026 (-77.3% YoY) suggests a potential shift or a highly cyclical innovation pipeline, especially as smaller categories like Healthcare Informatics show a modest resurgence in 2026 with 2 patents after a 100.0% decline in 2024.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
59 US filings (since 2023) · 4 categories · 4 themes
Devices and methods utilizing ultrasound energy for non-invasive or minimally invasive treatment, including focused ultrasound for tissue ablation, neuromodulation, or enhanced substance delivery.
Use of alternating electric or magnetic fields at specific frequencies and intensities to achieve therapeutic effects, such as inhibiting cell proliferation (e.g., cancer) or modulating cytokine production.
Design and engineering of specialized components within deposition systems, such as heaters, targets, susceptors, and chamber walls, to achieve precise control over process parameters like temperature, material flux, and plasma characteristics.
Therapeutic application of light, typically in the red or near-infrared spectrum, to stimulate cellular function, reduce inflammation, and promote healing, often involving specific wavelengths and irradiance levels.
Patents
Showing 1-10 of 69